Ingrid Dean, PharmD Candidate David Joffe, BSPharm, Preceptor   Florida A & M University College of Pharmacy   Vitamin D metabolism, serum calcium, and serum phosphate status may prove to play a vital role in patients with diabetes mellitus Types 1 and 2. The Osaka Vitamin D Study enrolled …

  U-500 Conversion Sheet – This easy to use sheet gives you the method to convert patients from U-100 insulin to Humulin U-500. This will work for patients whether they are on a pump, a pen or vial and syringe. I have included an example sheet to help you prepare …

Metformin appears to reduce the risk for pancreatic cancer in patients with diabetes, whereas insulin therapy appears to increase the risk, according to the results of a large case-control study. See This Week’s Item #8.  

A vaccine to prevent heart attacks could transform the treatment of heart disease. The new vaccine works by reversing the narrowing of the arteries, a leading cause of heart attacks. See This Week’s Item #5.  

From the results of a new study, it was concluded that poor glycemic control appears to be an independent risk factor for low HDL cholesterol in Type 2 diabetes. See This Week’s Item #4.  

Researchers at Huntsman Cancer Institute at the University of Utah have uncovered new information on the notion that sugar “feeds” tumors. The findings also have implications for other diseases such as diabetes.  

A team of researchers in Sweden, found that people classified as obese and those with pre-diabetes have raised levels of a protein called SPARC, that can cause tissue scarring. 

A retrospective analysis based on outpatient data from across Ontario, showed that the risk of dying or being hospitalized with heart failure, but not of MI, is lower among older diabetic patients taking pioglitazone (Actos, Takeda Pharmaceuticals) than in those taking rosiglitazone (Avandia, GlaxoSmithKline).

This study was done to determine whether the association observed between poor glycemic control and low HDL cholesterol in Type 2 diabetes is dependent on obesity and/or hypertriglyceridemia.

A vaccine to prevent heart attacks could transform the treatment of heart disease. The new vaccine works by reversing the narrowing of the arteries, a leading cause of heart attacks.